We are live on ! Find out more
HLVX

HilleVax

Delisted

HLVX was delisted on the 16th of September, 2025.

81 hedge funds and large institutions have $61.5M invested in HilleVax in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 30 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

7% more funds holding

Funds holding: 7681 (+5)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

1.92% less ownership

Funds ownership: 86%84.08% (-1.9%)

31% less capital invested

Capital invested by funds: $88.7M → $61.5M (-$27.2M)

33% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 30

Holders
81
Holders Change
+5
Holders Change %
+6.58%
% of All Funds
1.09%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
11
Increased
20
Reduced
30
Closed
6
Calls
Puts
Net Calls
Net Calls Change

HLVX Hedge Fund Activity: Q1 2025 in Review

81 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q1 2025, worth a combined $61.5M — down 31% from $88.7M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new HLVX positions and 6 closed out — a net gain of 5 holders — while 20 added to existing stakes and 30 trimmed.

The largest buyer was Trium Capital, opening a new position worth an estimated $699K. The largest seller was Millennium Management, cutting an estimated $475K.

  • 81 institutional investors held HilleVax (HLVX) as of Q1 2025, up from 76 in Q4 2024.
  • Funds reported $61.5M of HilleVax stock for Q1 2025, down 31% quarter-over-quarter.
  • 11 funds opened new HilleVax positions in Q1 2025 and 6 closed out, a net change of +5 holders.
  • The largest HilleVax buyer in Q1 2025 was Trium Capital, an estimated $699K added.
  • The largest HilleVax seller in Q1 2025 was Millennium Management, an estimated $475K sold.

Based on aggregated 13F filings for Q1 2025.